Horizon is a biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.
Horizon's global headquarters is in Dublin, Ireland and its U.S. headquarters is in Deerfield, Ill. The Company also has offices in Chicago, Ill.; South San Francisco, Calif.; Washington, D.C.; Gaithersburg, Md.; Rockville, Md.; Mannheim, Germany and a growing presence in Japan.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Sep 29, 2021 at 9:00 AM EDT
Virtual R&D Day for Investors and Analysts
Sep 10, 2021 at 10:15 AM EDT
Morgan Stanley 19th Annual Global Healthcare Conference (Virtual)
Aug 25, 2021 at 10:00 AM EDT
Handelsbanken Life Science Innovation Day 2021 (Virtual)
Aug 4, 2021 at 8:00 AM EDT
Horizon Therapeutics Second Quarter 2021 Earnings Call
Jun 22, 2021 at 10:00 AM EDT
BMO Biopharma Day: Spotlight on Rare Disease and Ophthalmology